Kanchan Sonkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kanchan Sonkar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Caitlin M. Tressler
The Johns Hopkins University Applied Imaging Mass Spectrometry Core and Service Center, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science The Johns Hopkins University School of Medicine Baltimore Maryland USA
2 shared publications - Kristine Glunde
Johns Hopkins University School of Medicine
2 shared publications Ethan Yang
The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research The Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publicationMenglin Cheng
The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research The Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publicationOluwatobi Adelaja
The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research The Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publicationRuoqing Cai
The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research The Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by Wiley in NMR in Biomedicine
- Vol. 36 (4) , e4770
A multimodal pipeline using NMR spectroscopy and MALDI‐TOF mass spectrometry imaging from the same tissue sample
NMR spectroscopy and matrix assisted laser desorption ionization mass spectrometry imaging (MALDI MSI) are both commonly used to detect large numbers of metabolites and lipids in metabolomic and lipidomic studies. We have demonstrated a new workflow, highlighting the benefits of both techniques to obtain metabolomic and lipidomic data, which has realized for the first time the combination of these two complementary and powerful technologies. NMR spectroscopy is frequently used to obtain quantitative metabolite information from cells and tissues. Lipid detection is also possible with NMR spectroscopy, with changes being visible across entire classes of molecules. Meanwhile, MALDI MSI provides relative measures of metabolite and lipid concentrations, mapping spatial information of many specific metabolite and lipid molecules across cells or tissues. We have used these two complementary techniques in combination to obtain metabolomic and lipidomic measurements from triple‐negative human breast cancer cells and tumor xenograft models. We have emphasized critical experimental procedures that ensured the success of achieving NMR spectroscopy and MALDI MSI in a combined workflow from the same sample. Our data show that several phospholipid metabolite species were differentially distributed in viable and necrotic regions of breast tumor xenografts. This study emphasizes the power of combined NMR spectroscopy–MALDI imaging to advance metabolomic and lipidomic studies.
- 1 June 2022
- Published by Wiley in NMR in Biomedicine
- Vol. 36 (4) , e4770
Open AccessA multimodal pipeline using NMR spectroscopy and MALDI‐TOF mass spectrometry imaging from the same tissue sample
NMR spectroscopy and matrix assisted laser desorption ionization mass spectrometry imaging (MALDI MSI) are both commonly used to detect large numbers of metabolites and lipids in metabolomic and lipidomic studies. We have demonstrated a new workflow, highlighting the benefits of both techniques to obtain metabolomic and lipidomic data, which has realized for the first time the combination of these two complementary and powerful technologies. NMR spectroscopy is frequently used to obtain quantitative metabolite information from cells and tissues. Lipid detection is also possible with NMR spectroscopy, with changes being visible across entire classes of molecules. Meanwhile, MALDI MSI provides relative measures of metabolite and lipid concentrations, mapping spatial information of many specific metabolite and lipid molecules across cells or tissues. We have used these two complementary techniques in combination to obtain metabolomic and lipidomic measurements from triple‐negative human breast cancer cells and tumor xenograft models. We have emphasized critical experimental procedures that ensured the success of achieving NMR spectroscopy and MALDI MSI in a combined workflow from the same sample. Our data show that several phospholipid metabolite species were differentially distributed in viable and necrotic regions of breast tumor xenografts. This study emphasizes the power of combined NMR spectroscopy–MALDI imaging to advance metabolomic and lipidomic studies.
- 11 June 2019
- Published by Wiley in NMR in Biomedicine
- Vol. 32 (10) , e4112
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which leads to elevated levels of phosphocholine and glycerophosphocholine in all types of cancer tested so far. Magnetic resonance spectroscopy applications have played a key role in detecting these elevated choline phospholipid metabolites. To date, the majority of cancer‐related studies have focused on phosphocholine and the Kennedy pathway, which constitutes the biosynthesis pathway for membrane phosphatidylcholine. Fewer and more recent studies have reported on the importance of glycerophosphocholine in cancer. In this review article, we summarize the recent literature on glycerophosphocholine metabolism with respect to its cancer biology and its detection by magnetic resonance spectroscopy applications.
- 11 June 2019
- Published by Wiley in NMR in Biomedicine
- Vol. 32 (10) , e4112
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which leads to elevated levels of phosphocholine and glycerophosphocholine in all types of cancer tested so far. Magnetic resonance spectroscopy applications have played a key role in detecting these elevated choline phospholipid metabolites. To date, the majority of cancer‐related studies have focused on phosphocholine and the Kennedy pathway, which constitutes the biosynthesis pathway for membrane phosphatidylcholine. Fewer and more recent studies have reported on the importance of glycerophosphocholine in cancer. In this review article, we summarize the recent literature on glycerophosphocholine metabolism with respect to its cancer biology and its detection by magnetic resonance spectroscopy applications.